Barclays Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $570
BenzingaMay 3 01:50
Barclays: The IDEXX Laboratories (IDXX.US) rating was maintained, and the target price was adjusted from $655.00 to $570.00.
Zhitong FinanceMay 3 01:50
IDEXX Laboratories Analyst Ratings
BenzingaMay 3 01:49
Redburn Atlantic Adjusts Price Target on IDEXX Laboratories to $500 From $460
MT NewswiresMay 2 21:23
BofA Securities Cuts Price Target on IDEXX Laboratories to $595 From $600, Maintains Neutral Rating
MT NewswiresApr 30 22:02
Barclays Maintains Overweight on IDEXX Laboratories, Raises Price Target to $655
BenzingaFeb 6 23:45
IDEXX Laboratories Analyst Ratings
BenzingaFeb 6 23:43
Piper Sandler Downgrades Idexx to Neutral, Cites Macro Headwinds
Seeking AlphaJan 31 05:08
IDEXX Laboratories Analyst Ratings
BenzingaJan 30 18:34
Goldman Sachs Maintains Buy on IDEXX Laboratories, Raises Price Target to $650
BenzingaJan 17 23:18
IDEXX Laboratories Analyst Ratings
BenzingaJan 17 23:17
Piper Sandler Maintains Overweight on IDEXX Laboratories, Raises Price Target to $525
BenzingaNov 6, 2023 23:19
IDEXX Laboratories Analyst Ratings
BenzingaNov 6, 2023 23:18
Goldman Sachs Maintains Buy on IDEXX Laboratories, Lowers Price Target to $500
BenzingaNov 3, 2023 22:42
JP Morgan Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $550
BenzingaNov 3, 2023 05:44
Barclays Maintains Overweight on IDEXX Laboratories, Raises Price Target to $592
BenzingaNov 2, 2023 23:21
IDEXX Laboratories Analyst Ratings
BenzingaNov 2, 2023 23:20
IDEXX Laboratories Analyst Ratings
BenzingaOct 30, 2023 23:09
Stifel Maintains Hold on IDEXX Laboratories, Lowers Price Target to $500
BenzingaSep 15, 2023 20:51
IDEXX Laboratories Analyst Ratings
BenzingaSep 15, 2023 20:50
No Data
No Data